Fernando Meton de Alencar Câmara Vieira

Author

Also Known As

F.M. Vieira, Fernando M Vieira, Fernando M. Vieira, Fernando Meton VIEIRA, Fernando Meton Vieira, Fernando Meton de Alencar Camara Vieira, Fernando Meton de Alencar Câmara Vieira, Francine Mônica Vieira

Publications

647

Citations

H-Index

Concepts

All Affiliations

Instituto Nacional do Câncer Centro de Pesquisas Oncológicas

About

Fernando Meton de Alencar Câmara Vieira is an author at Instituto Nacional do Câncer specializing in radiation oncology, health sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	2	2	168
2	Medicine	2	2	168
3	Surgical Oncology	1	1	141
4	Cancer Epidemiology	1	1	27
5	Cancer Therapeutics	1	1	27

Fernando Meton de Alencar Câmara Vieira

Publications

535

Citations

H-Index

Page 1

	Year	Citations
Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2 Mauro Zukin, Carlos H. Barrios, José Rodrigues Pereira, Journal of Clinical Oncology	2013	237
Nonoperative management of rectal cancer after chemoradiation opposed to resection after complete clinical response. A comparative study Rodrigo Otávio Araújo, Marcus Valadão, Daniel Lago Borges, European Journal of Surgical Oncology Surgical OncologyRadiation TherapyGastrointestinal OncologyColorectal SurgeryCancer Recurrence	2015	141
Phase 1 study of cetuximab in combination with 5‐fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma Luis O. Olivatto, Fernando Meton de Alencar Câmara Vieira, Bruno Vilhena Pereira, Cancer	2013	66
KRAS mutations: variable incidences in a Brazilian cohort of 8,234 metastatic colorectal cancer patients Carlos Gil Ferreira, Veronica Aran, Ilana Zalcberg-Renault, BMC Gastroenterology	2014	41
A randomized phase III trial of single-agent pemetrexed (P) versus carboplatin and pemetrexed (CP) in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2. Rogério Lilenbaum, Mauro Zukin, José Rodrigues Pereira, Journal of Clinical Oncology Cancer ManagementOncologyMetronomic TherapyClinical TrialsVersus Carboplatin	2012	27
Survival and prognostic factors in patients with Non-Small Cell Lung Cancer treated in private health care Clarissa Baldotto, Mauro Zukin, Fernando Meton de Alencar Câmara Vieira, Revista Brasileira de Epidemiologia	2014	23

Page 1